In the Research Letter titled “Trends in Pricing and Out-of-Pocket Spending on Entecavir Among Commercially Insured Patients, 2014-2018”,[1] published January 21, 2022, an older version of the Figure was inadvertently published. The Figure included data points for out-of-pocket spending that incorrectly included a denominator of patients taking both brand name and generic entecavir, rather than generic only. This article has been corrected.[1]
Authors: Jonathan D Alpern; Heesoo Joo; Ben Link; Antonio Ciaccia; William M Stauffer; Nathan C Bahr; Thomas M Leventhal Journal: JAMA Netw Open Date: 2022-01-04